RecruitingPhase 1 / Phase 2NCT06710756
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Sponsor: Perspective Therapeutics
Dallas, TX · Houston, TX · +14 more sites
Colorectal Cancer clinical trials in Dallas, TX
32 recruiting colorectal cancer studies with a site in Dallas, TX.
RecruitingPhase 3NCT06997497
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Sponsor: Merck Sharp & Dohme LLC
Dallas, TX · Denison, TX · +45 more sites
RecruitingPhase 1NCT07114601
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Sponsor: Eli Lilly and Company
Dallas, TX · Houston, TX · +14 more sites
RecruitingPhase 3NCT07228832
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Sponsor: Summit Therapeutics
Dallas, TX · Fort Worth, TX · +109 more sites
RecruitingPhase 1NCT06218914
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Sponsor: AstraZeneca
Dallas, TX · Galveston, TX · Houston, TX · +15 more sites
RecruitingPhase not listedNCT07124000
DESTINY-PANTUMOUR04
Sponsor: AstraZeneca
Dallas, TX · +17 more sites
RecruitingPhase 1NCT07277270
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
Sponsor: GlaxoSmithKline
Dallas, TX · +4 more sites
RecruitingPhase 3NCT05863195
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Sponsor: ECOG-ACRIN Cancer Research Group
Dallas, TX · +59 more sites
RecruitingPhase 1 / Phase 2NCT06047379
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Sponsor: Neonc Technologies, Inc.
Dallas, TX · +7 more sites
RecruitingPhase not listedNCT05059444
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Sponsor: Guardant Health, Inc.
Dallas, TX · Edinburg, TX · Forth Worth, TX · +30 more sites
RecruitingPhase 1 / Phase 2NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Sponsor: Daiichi Sankyo
Amarillo, TX · Dallas, TX · Pearland, TX · +15 more sites
RecruitingPhase 1 / Phase 2NCT04657068
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Sponsor: Artios Pharma Ltd
Austin, TX · Dallas, TX · +38 more sites
RecruitingPhase 1 / Phase 2NCT03526835
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Sponsor: Merus B.V.
Dallas, TX · Houston, TX · Tyler, TX · +28 more sites
RecruitingPhase 1NCT06764771
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
Sponsor: Bristol-Myers Squibb
Dallas, TX · +3 more sites
RecruitingPhase 1NCT06974110
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
Sponsor: MOMA Therapeutics
Dallas, TX · Houston, TX · +7 more sites
RecruitingPhase 2NCT06695845
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Sponsor: Jazz Pharmaceuticals
Amarillo, TX · Dallas, TX · Houston, TX · +14 more sites
RecruitingPhase 1NCT07337525
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
Sponsor: Pilatus Biosciences Inc
Dallas, TX · Houston, TX · +1 more sites
RecruitingPhase 2 / Phase 3NCT03051464
Randomizing Two Radiotherapy Boost Options to Avoid Rectal Cancer Surgery
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital
Dallas, TX
RecruitingPhase 1 / Phase 2NCT07432633
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
Sponsor: Blue Earth Diagnostics
Dallas, TX
RecruitingPhase 1NCT07540572
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Sponsor: IDEAYA Biosciences
Austin, TX · Dallas, TX · Fort Worth, TX · +8 more sites
RecruitingPhase 1 / Phase 2NCT05552755
Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
Sponsor: Recursion Pharmaceuticals Inc.
Dallas, TX · Houston, TX · +15 more sites
RecruitingPhase 1NCT06917079
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Dallas, TX · Houston, TX · San Antonio, TX · +13 more sites
RecruitingPhase not listedNCT04739072
Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study
Sponsor: M.D. Anderson Cancer Center
Dallas, TX · Houston, TX · +7 more sites
RecruitingPhase 1 / Phase 2NCT05379985
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Sponsor: Revolution Medicines, Inc.
Austin, TX · Dallas, TX · Houston, TX · +18 more sites
RecruitingPhase not listedNCT07559825
Early-Onset Colorectal Cancer Patients Too Young for Screening
Sponsor: Methodist Health System
Dallas, TX
RecruitingPhase 2NCT07033026
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
Sponsor: NGM Biopharmaceuticals, Inc
Dallas, TX · Kingwood, TX · Laredo, TX · +10 more sites
RecruitingPhase 1 / Phase 2NCT07030257
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Sponsor: Tasca Therapeutics
Dallas, TX · San Antonio, TX · +11 more sites
RecruitingPhase 1 / Phase 2NCT07148128
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
Sponsor: Auricula Biosciences Inc.
Dallas, TX · San Antonio, TX
RecruitingPhase 4NCT04373564
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Sponsor: Guerbet
Dallas, TX · Houston, TX · +14 more sites
RecruitingPhase 1NCT07317505
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
Sponsor: Conjupro Biotherapeutics, Inc.
Dallas, TX · +2 more sites
RecruitingPhase 1NCT05746897
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
Sponsor: Hefei TG ImmunoPharma Co., Ltd.
Dallas, TX · +1 more sites
Not yet recruitingPhase 1NCT07650357
A Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)
Sponsor: Clasp Therapeutics, Inc.
Dallas, TX · +3 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.